CAS 1226917-67-4

Fórmula: C28H32Cl2N4O

InChI: InChI=1S/C28H30N4O.2ClH/c29-18-21-5-8-23-19-32(16-13-22(23)17-21)15-12-20-6-9-24(10-7-20)31-28(33)26-11-14-30-27-4-2-1-3-25(26)27;;/h1-5,8,11,14,17,20,24H,6-7,9-10,12-13,15-16,19H2,(H,31,33);2*1H

Chave InChI: HEZIOTGUXSPDAK-UHFFFAOYSA-N

SMILES: C1CC(CCC1CCN2CCC3=C(C2)C=CC(=C3)C#N)NC(=O)C4=CC=NC5=CC=CC=C45.Cl.Cl

N-((1r,4r)-4-(2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)quinoline-4-carboxamide dihydrochloride

CAS: 1226917-67-4

N-((1r,4r)-4-(2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)quinoline-4-carboxamide dihydrochloride

Fórmula: C₂₈H₃₂Cl₂N₄O

Pureza: ≥98%

Peso molecular: 511.49

Ref: 54-OR1115906

N-((1r,4r)-4-(2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)quinoline-4-carboxamide dihydrochloride

CAS: 1226917-67-4

Fórmula: C₂₈H₃₂Cl₂N₄O

Pureza: 98%

Peso molecular: 511.4859

Ref: IN-DA009IH0

SB 277011A Dihydrochloride

CAS: 1226917-67-4

SB 277011A is a dopamine receptor agonist that has been shown to enhance the effects of dopamine in animal models. SB 277011A has been shown to reduce the discounting of delayed rewards and improve performance on neurobehavioral tasks in rats. These effects are thought to be due to its ability to bind with high affinity at D2 receptors, which are primarily found in the nucleus accumbens and prefrontal cortex. This drug has not yet been tested for clinical use, but it may be useful for treating addiction, Parkinson's disease, and other disorders that involve the dopamine system.

Fórmula: C₂₈H₃₀N₄O•2HCl

Pureza: Min. 95%

Peso molecular: 511.5 g/mol

Ref: 3D-BZB91767

SB-277011 dihydrochloride

CAS: 1226917-67-4

SB-277011 dihydrochloride: potent, selective D3 antagonist; orally bioavailable; crosses blood-brain barrier; pKi 8.0 for D3 receptor.

Fórmula: C₂₈H₃₂Cl₂N₄O

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 511.49

Ref: TM-T12861L